Limbach Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Limbach Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Limbach Holdings Inc LMB.OQ reported quarterly adjusted earnings of 39 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 64 cents. The mean expectation of five analysts for the quarter was for earnings of 72 cents per share. Wall Street expected results to range from 60 cents to 80 cents per share.
Revenue rose 21.9% to $173.46 million from a year ago; analysts expected $177.25 million.
Limbach Holdings Inc's reported EPS for the quarter was 39 cents.
The company reported quarterly net income of $4.75 million.
Limbach Holdings Inc shares had fallen by 4.9% this quarter and lost 5.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 9.8% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the construction & engineering peer group is also "buy"
Wall Street's median 12-month price target for Limbach Holdings Inc is $110.00, about 33.4% above its last closing price of $73.25
This summary was machine generated from LSEG data August 4 at 09:44 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.72 | 0.39 | Missed |
Mar. 31 2026 | 0.03 | 0.36 | Beat |
Dec. 31 2025 | 1.04 | 1.02 | Missed |
Sep. 30 2025 | 0.85 | 0.73 | Missed |
Recent news on Limbach Holdings
See all newsU.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC Solutions
U.S. RESEARCH ROUNDUP-Caterpillar, Eli Lilly, McKesson
Limbach Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Limbach Q2 revenue misses estimates, cuts adjusted EBITDA forecast
Brief: Limbach Holdings Q2 Revenue USD 173.457 Million Vs. IBES Estimate USD 177.3 Million